Related Articles
Mps1 is associated with the BRAFV600E mutation but does not rely on the classic RAS/RAF/MEK/ERK signaling pathway in thyroid carcinoma
MPS1 kinase as a potential therapeutic target in medulloblastoma
Association between BRAFV600E mutation and the clinicopathological features of solitary papillary thyroid microcarcinoma
Energy‑stress‑mediated activation of AMPK sensitizes MPS1 kinase inhibition in triple‑negative breast cancer
Mutations in BRAF codons 594 and 596 predict good prognosis in melanoma